Comparison of 1-year patient and graft survival rates between preemptive and dialysed simultaneous pancreas and kidney transplant recipients

Transplantation Proceedings
T GrochowieckiA Kański

Abstract

It is well known that the main decrease in graft and recipient survival rates is observed during the first 12 months after transplantation. Improving results during this period seems to be crucial for the late outcome. The aim of this study was to compare 1-year survival rates of dialyzed and preemptive pancreas and renal graft recipients and their graft function. From November 1999 to January 2005, 42 whole simultaneous pancreas and kidney transplantations (spktx) were stratified into group I (n = 13): recipients who received a preemptive pancreas and kidney transplant versus group II (n = 29): previously dialyzed spktx recipients. The mean time of dialysis for group II was 39 +/- 16.5 months. We assessed 1-year cumulative survival rates for recipients and grafts for each group. The 1-year cumulative survival rate for preemptive graft recipients was significantly higher than that for dialyzed patients before spktx (100% vs 69%; P = .05). For groups I and II 1-year cumulative graft survival rates for kidney grafts were 100% and 89%, respectively, and for pancreatic grafts 84% and 65.5%, respectively. There was a significant improvement in the 1-year survival rate of preemptive spktx recipients compared with patients dialyzed be...Continue Reading

References

Jun 22, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P StenvinkelJ Bergström
Dec 6, 2003·JAMA : the Journal of the American Medical Association·Jeffrey M VenstromDavid M Harlan

❮ Previous
Next ❯

Citations

Apr 23, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christian Morath, Martin Zeier
Dec 16, 2009·Clinical Transplantation·C MorathM Zeier
May 18, 2011·Journal of Intensive Care Medicine·Joseph R Scalea, Matthew Cooper
Sep 21, 2016·World Journal of Nephrology·Usama Abdel Azim Sharaf El DinDina Ossama Abdulazim
Jun 26, 2012·Transplantation·Mathieu PageBernard Allaouchiche
Oct 18, 2012·The Journal of Clinical Endocrinology and Metabolism·Kathie L HermayerRickey E Carter
Sep 18, 2017·Digestive Diseases and Sciences·Augusto LauroKishore R Iyer
Jul 11, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Ugo BoggiThierry Berney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of the American College of Surgeons
Devin E EckhoffA G Diethelm
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
M H AndersenE Fosse
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
C L JacobsArthur J Matas
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
James F WhitingMaria Kjerulf
© 2021 Meta ULC. All rights reserved